$192.87 B
Share price
Change (1 day)
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Novartis (NVS) Fails to deliver data

Key failure to deliver metrics for Novartis:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Novartis (NVS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Novartis (NVS) - since 2013

Volume in USD (price x number of shares), data since 2013

Novartis (NVS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$30.53 M-60.07%
2023$76.46 M-33.95%
2022$0.11 B13.59%
2021$0.10 B-28.35%
2020$0.14 B-21.65%
2019$0.18 B18.03%
2018$0.15 B48.59%
2017$0.10 B-62.29%
2016$0.27 B-38.77%
2015$0.44 B149.55%
2014$0.17 B59.41%
2013$0.11 B

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$0.14 B$0.60 B๐Ÿ‡บ๐Ÿ‡ธ USA
$31.87 M$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA
$62.08 M$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
$26.25 M$54.4 M๐Ÿ‡ซ๐Ÿ‡ท France
$8.48 M$0.18 B๐Ÿ‡บ๐Ÿ‡ธ USA
$0.19 B$0.29 B๐Ÿ‡บ๐Ÿ‡ธ USA
$0.10 B$0.17 B๐Ÿ‡ฌ๐Ÿ‡ง UK
$15.53 M$26.02 M๐Ÿ‡ฌ๐Ÿ‡ง UK
$6.66 M$42.47 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel